Navigation Links
InHealth awards grant to research team at Hartford Hospital
Date:11/11/2010

WASHINGTON, DCThe Institute for Health Technology Studies (InHealth) has awarded a grant totaling more than $238,000 to a research team at the Helen & Harry Gray Cancer Center at Hartford Hospital in Connecticut to study how various prostate cancer treatments affect a patient's "social capital"the ability to continue working productively in a paying job.

Prostate cancer survivorship is growing. The disease is the second most common cancer diagnosed in men, with one of the best survivorship rates: according to the American Cancer Society, the five-year survival rate is nearly 100%. The Hartford Hospital study will examine how treating the disease with aggressive therapy affects quality of life and the career trajectories of men between the ages of 45 and 65.

The study will include men treated for prostate cancer between 2001 and 2010, a period in which the technology used to treat the disease underwent significant change: robotic-aided laparoscopy replaced classical open surgery; and standard radiation therapy moved from three-dimensional conformal radiotherapy (3D-CRT) to intensity-modulated radiation therapy (IMRT) with daily imaging.

"Published scientific research, some sponsored by InHealth, shows that less medical technology means more hospital stays and intensive care, more recovery time and lost efficiency for business, and more productivity lost to disabilities," says Martyn Howgill, InHealth's executive director. "While information about the costs of these technologies is readily available, there is less information about their overall economic effects at either the patient or societal level, as the recent discussion of healthcare reform has exposed."

The Hartford team will survey three groups of early-stage prostate cancer patients: those treated with brachytherapy using radioactive seeds, those treated with robot-assisted and open surgical techniques, and those treated with varying forms of external beam radiation. Patients will have been actively working when treated, and will be asked to recall their experience, including work frequency at time of diagnosis, during and after treatment, and currently. The researchers will also collect data on paid leaves, unemployment compensation, features of employment, satisfaction with current work compared with the time of diagnosis, and the amount of time elapsed before a patient was able to return to work, among other issues.

Researchers will classify employment and salary data for each patient before treatment and six months and three years after. This information will then be compared with data from the Bureau of Labor Statistics, generating an economic measure of each patient's social capital.

The study, "Technology and Access to Work During and After Prostate Cancer Treatment," will be led by principal investigator Andrew L. Salner, MD, director of the Helen & Harry Gray Cancer Center and associate clinical professor at the University of Connecticut School of Medicine. It will involve researchers from the Hartford Hospital Research Program; the University of Connecticut, Storrs; and the cole Libre des Hautes tudes, in New York City.

Salner and his team will recruit patients from Hartford Hospital's Comprehensive Prostate Center Database, launched in 2006, which documents the entire clinical process from diagnosis through treatment and follow-up for all patients receiving active treatment from any urologist or radiation oncologist affiliated with Hartford Hospital. Quality of life data are also collected. Patients treated before 2006 will be identified through the Hartford Hospital Cancer Registry.

"We are most pleased to have been selected for this prestigious research funding from InHealth," said Salner. "It certainly allows the study of how new and innovative technologies can impact cancer patients' quality of life, their return to productive normalcy, and the environment in which they function."

Findings from the study are expected in late 2011.


'/>"/>

Contact: Caitlin Hool
caitlin.hool@gabbe.com
212-220-4444
InHealth: The Institute for Health Technology Studies
Source:Eurekalert

Related medicine news :

1. Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards
2. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
3. International Diabetes Federation awards $2 million to 9 global diabetes research projects
4. Highmark Foundation Awards $120,000 to the American Heart Association
5. Diane von Furstenberg Establishes The DVF Awards to Recognize Outstanding Women Leaders
6. Siemens Awards for Advanced Placement Honor Top U.S. Science and Math Students and Teachers
7. Awards Strengthen Stonhard's Reputation for High-Performing Floors in the World's Most Prominent Pharmaceutical Facilities
8. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
9. AADR awards the 2010 Distinguished Mentoring Award to Irwin D. Mandel
10. AADR awards the 2010 AADR William B. Clark Fellowship to Isabel Gay
11. AADR awards the 2010 Distinguished Scientist Award to John Greenspan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental ... Your Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related ... and prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... was set up in 2006 as a non-profit organization to unite pharmaceutical and ...
(Date:12/8/2016)... ... 08, 2016 , ... Healthcare is in flux. The GOP ... the mass media launching of story movements to highlight what's most unfair about ... experiences; such a movement can generate the network power to improve healthcare policies ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, an ... around the greater Phoenix metropolitan region, is announcing a charity event to provide ... the Homeless Youth Connection is to promote community awareness of the ongoing needs ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016   TriNetX , the health research ... signed a membership agreement to join the ... new cures. The TriNetX network is ... patients globally, biopharmaceutical companies and contract research organizations ... design, site selection, patient recruitment, and collaborative research ...
(Date:12/8/2016)... , Dec. 8, 2016  Valeant Pharmaceuticals International, ... VRX) ("Valeant") today announced positive results from a ... to assess the safety and efficacy of IDP-118 ... of plaque psoriasis. Within the ... moderate to severe psoriasis, IDP-118 showed statistical significance ...
(Date:12/8/2016)... 8, 2016  EIP Pharma, LLC ( www.eippharma.com ... for neflamapimod (previously code named VX-745), with the ... trials that demonstrated significant Alzheimer,s disease relevant pharmacological ... and Study 303 (6-week treatment) are the subject ... Disease (CTAD) scientific conference in San ...
Breaking Medicine Technology: